Skip to main content

Telemedicine in Cancer Control Programs in Developing Countries

  • Chapter
  • First Online:
Breast and Gynecological Cancers

Abstract

The success of a cancer screening and early diagnosis program is critically dependent on the skill of the healthcare professionals involved. Initial training, continuing education, and consultation as needed are best achieved via telemedicine. The various components of such support for screening and diagnosis of breast and gynecological cancers are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

CCPPZ:

Cervical Cancer Prevention Program in Zambia

CIDRZ:

Center for Infectious Disease ­Research in Zambia

DAD:

Data acquisition device

DART:

Digital camera assessment of the reproductive tract

eC3:

Electronic cervical cancer control

EDI:

Enhanced digital imaging

HIV:

Human immunodeficiency virus

HPV:

Human papilloma virus

LEEP:

Loop electrosurgical excision ­procedure

Pap:

Papanicolaou

PIA:

Photographic inspection with acetic acid

SMS:

Short message service

VIA:

of the cervix with acetic acid

VILI:

Visualization of the cervix with Lugol’s iodine, i.e., Schiller’s test

References

  1. Sankaranarayanan R, Sauvaget C, Ramadas K, Ngoma T, Teguete I, Muwonge R, et al. Clinical trials of cancer screening in the developing world and their impact on cancer healthcare. Ann Oncol. 2011;22 Suppl 7:vii20–8.

    Article  PubMed  Google Scholar 

  2. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011;378(9801):1461–84.

    Article  PubMed  Google Scholar 

  3. Igene H. Global health inequalities and breast cancer: an impending public health problem for developing countries. Breast J. 2008;14(5):428–34.

    Article  PubMed  Google Scholar 

  4. Ginsberg GM, Lauer JA, Zelle S, Baeten S, Baltussen R. Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study. BMJ. 2012;344:e614.

    Article  PubMed  Google Scholar 

  5. Panieri E. Breast cancer screening in developing countries. Best Pract Res Clin Obstet Gynaecol. 2012;26(2):283–90.

    Article  PubMed  Google Scholar 

  6. Granot Y, Ivorra A, Rubinsky B. A new concept for medical imaging centered on cellular phone technology. PLoS One. 2008;3(4):e2075.

    Article  PubMed  Google Scholar 

  7. Leader JK, Hakim CM, Ganott MA, Chough DM, Wallace LP, Clearfield RJ, et al. A multisite telemammography system for remote management of screening mammography: an assessment of technical, operational, and clinical issues. J Digit Imaging. 2006;19(3):216–25.

    Article  PubMed  Google Scholar 

  8. Szymas J, Wolf G. Telepathology by the internet. Adv Clin Path. 1998;2(2):133–5.

    PubMed  Google Scholar 

  9. Hitchcock CL. The future of telepathology for the developing world. Arch Pathol Lab Med. 2011;135(2):211–4.

    PubMed  Google Scholar 

  10. Hitchcock CL, Hitchcock LE. Three years of experience with routine use of telepathology in assessment of excisional and aspirate biopsies of breast lesions. Croat Med J. 2005;46(3):449–57.

    PubMed  Google Scholar 

  11. Lopez AM, Graham AR, Barker GP, Richter LC, Krupinski EA, Lian F, et al. Virtual slide telepathology enables an innovative telehealth rapid breast care clinic. Semin Diagn Pathol. 2009;26(4):177–86.

    Article  PubMed  Google Scholar 

  12. Vazir H, Loane MA, Wootton R. A pilot study of low-cost dynamic telepathology using the public telephone network. Adv Clin Path. 1998;2(2):151.

    PubMed  Google Scholar 

  13. Singh N, Akbar N, Sowter C, Lea KG, Wells CA. Telepathology in a routine clinical environment: implementation and accuracy of diagnosis by robotic microscopy in a one-stop breast clinic. J Pathol. 2002;196(3):351–5.

    Article  PubMed  Google Scholar 

  14. Sainsbury R, Haward B, Rider L, Johnston C, Round C. Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet. 1995;345(8960):1265–70.

    Article  PubMed  CAS  Google Scholar 

  15. Axford AT, Askill C, Jones AJ. Virtual multidisciplinary teams for cancer care. J Telemed Telecare. 2002;8 Suppl 2:3–4.

    Article  PubMed  Google Scholar 

  16. Kunkler IH, Prescott RJ, Lee RJ, Brebner JA, Cairns JA, Fielding RG, et al. TELEMAM: a cluster randomised trial to assess the use of telemedicine in multi-disciplinary breast cancer decision making. Eur J Cancer. 2007;43(17):2506–14.

    Article  PubMed  CAS  Google Scholar 

  17. Kunkler IH, Rafferty P, Hill D, Henry M, Foreman D. A pilot study of tele-oncology in Scotland. J Telemed Telecare. 1998;4(2):113–9.

    Article  PubMed  CAS  Google Scholar 

  18. Barry N, Campbell P, Reed N, Reid ME, Bower DJ, Norrie J, et al. Implementation of videoconferencing to support a managed clinical network in Scotland: lessons learned during the first 18 months. J Telemed Telecare. 2003;9 Suppl 2:S7–9.

    Article  PubMed  Google Scholar 

  19. Fielding RG, Macnab M, Swann S, Kunkler IH, Brebner J, Prescott RJ, et al. Attitudes of breast cancer professionals to conventional and telemedicine-delivered multidisciplinary breast meetings. J Telemed Telecare. 2005;11 Suppl 2:S29–34.

    Article  PubMed  Google Scholar 

  20. Kunkler IH, Fielding RG, Brebner J, Prescott R, Maclean JR, Cairns J, et al. A comprehensive approach for evaluating telemedicine-delivered multidisciplinary breast cancer meetings in southern Scotland. J Telemed Telecare. 2005;11 Suppl 1:71–3.

    Article  PubMed  Google Scholar 

  21. Odigie VI, Yusufu LM, Dawotola DA, Ejagwulu F, Abur P, Mai A, et al. The mobile phone as a tool in improving cancer care in Nigeria. Psychooncology. 2012;21(3):332–5.

    Article  PubMed  CAS  Google Scholar 

  22. Klasnja P, Hartzler A, Powell C, Phan G, Pratt W. Health weaver mobile: designing a mobile tool for managing personal health information during cancer care. AMIA Annu Symp Proc. 2010;2010:392–6.

    PubMed  Google Scholar 

  23. Kearney N, McCann L, Norrie J, Taylor L, Gray P, McGee-Lennon M, et al. Evaluation of a mobile phone-based, advanced symptom management system (ASyMS) in the management of chemotherapy-related toxicity. Support Care Cancer. 2009;17(4):437–44.

    Article  PubMed  CAS  Google Scholar 

  24. McCann L, Maguire R, Miller M, Kearney N. Patients’ perceptions and experiences of using a mobile phone-based advanced symptom management system (ASyMS) to monitor and manage chemotherapy related toxicity. Eur J Cancer Care (Engl). 2009;18(2):156–64.

    Article  CAS  Google Scholar 

  25. Parkin DM, Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine. 2006;24 Suppl 3:S3/11–25.

    Google Scholar 

  26. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118(12):3030–44.

    Article  PubMed  CAS  Google Scholar 

  27. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immuno-deficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst. 2000;92(18):1500–10.

    Article  PubMed  CAS  Google Scholar 

  28. Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA. Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst. 2009;101(16):1120–30.

    Article  PubMed  Google Scholar 

  29. Tran K, Ayad M, Weinberg J, Cherng A, Chowdhury M, Monir S, et al. Mobile teledermatology in the developing world: implications of a feasibility study on 30 Egyptian patients with common skin diseases. J Am Acad Dermatol. 2011;64(2):302–9.

    Article  PubMed  Google Scholar 

  30. Kaddu S, Soyer HP, Gabler G, Kovarik C. The Africa Teledermatology Project: preliminary experience with a sub-Saharan teledermatology and e-learning program. J Am Acad Dermatol. 2009;61(1):155–7.

    Article  PubMed  Google Scholar 

  31. Weinberg J, Kaddu S, Gabler G, Kovarik C. The African Teledermatology Project: providing access to dermatologic care and education in sub-Saharan Africa. Pan Afr Med J. 2009;3:16.

    PubMed  Google Scholar 

  32. Massone C, Lozzi GP, Wurm E, Hofmann-Wellenhof R, Schoellnast R, Zalaudek I, et al. Cellular phones in clinical teledermatology. Arch Dermatol. 2005;141(10):1319–20.

    Article  PubMed  Google Scholar 

  33. Schreier G, Hayn D, Kastner P, Koller S, Salmhofer W, Hofmann-Wellenhof R. A mobile-phone based teledermatology system to support self-management of patients suffering from psoriasis. Conf Proc IEEE Eng Med Biol Soc. 2008;2008:5338–41.

    PubMed  Google Scholar 

  34. Shapiro M, James WD, Kessler R, Lazorik FC, Katz KA, Tam J, et al. Comparison of skin biopsy triage decisions in 49 patients with pigmented lesions and skin neoplasms: store-and-forward teledermatology vs face-to-face dermatology. Arch Dermatol. 2004;140(5):525–8.

    Article  PubMed  Google Scholar 

  35. Massone C, Hofmann-Wellenhof R, Ahlgrimm-Siess V, Gabler G, Ebner C, Soyer HP. Melanoma screening with cellular phones. PLoS One. 2007;2(5):e483.

    Article  PubMed  Google Scholar 

  36. Kroemer S, Fruhauf J, Campbell TM, Massone C, Schwantzer G, Soyer HP, et al. Mobile teledermatology for skin tumour screening: diagnostic accuracy of clinical and dermoscopic image tele-evaluation using cellular phones. Br J Dermatol. 2011;164(5):973–9.

    Article  PubMed  CAS  Google Scholar 

  37. Massone C, Brunasso AM, Campbell TM, Soyer HP. Mobile teledermoscopy—melanoma diagnosis by one click? Semin Cutan Med Surg. 2009;28:203–5.

    Article  PubMed  CAS  Google Scholar 

  38. Lamel SA, Haldeman KM, Ely H, Kovarik CL, Pak H, Armstrong AW. Application of mobile teledermatology for skin cancer screening. J Am Acad Dermatol. 2012;67(4):576–81.

    Article  PubMed  Google Scholar 

  39. Azfar RS, Weinberg JL, Cavric G, Lee-Keltner IA, Bilker WB, Gelfand JM, et al. HIV-positive patients in Botswana state that mobile teledermatology is an acceptable method for receiving dermatology care. J Telemed Telecare. 2011;17(6):338–40.

    Article  PubMed  Google Scholar 

  40. Scheinfeld N, Fisher M, Genis P, Long H. Evaluating patient acceptance of a teledermatology link of an urban urgent-care dermatology clinic run by residents with board certified dermatologists. Skinmed. 2003;2(3):159–62.

    Article  PubMed  Google Scholar 

  41. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94(2):153–6.

    Article  PubMed  CAS  Google Scholar 

  42. Roblyer D, Richards-Kortum R, Park SY, Adewole I, Follen M. Objective screening for cervical cancer in developing nations: lessons from Nigeria. Gynecol Oncol. 2007;107(1 Suppl 1):S94–7.

    Article  PubMed  Google Scholar 

  43. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. J Low Genit Tract Dis. 2003;7(2):67–86.

    Article  PubMed  Google Scholar 

  44. Parham GP, Mwanahamuntu MH, Pfaendler KS, Sahasrabuddhe VV, Myung D, Mkumba G, et al. eC3—a modern telecommunications matrix for cervical cancer prevention in Zambia. J Low Genit Tract Dis. 2010;14(3):167–73.

    Article  PubMed  Google Scholar 

  45. Quinley KE, Gormley RH, Ratcliffe SJ, Shih T, Szep Z, Steiner A, et al. Use of mobile telemedicine for cervical cancer screening. J Telemed Telecare. 2011;17(4):203–9.

    Article  PubMed  Google Scholar 

  46. Mwanahamuntu MH, Sahasrabuddhe VV, Kapambwe S, Pfaendler KS, Chibwesha C, Mkumba G, et al. Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia. PLoS Med. 2011;8(5):e1001032.

    Article  PubMed  Google Scholar 

  47. Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, et al. HPV screening for cervical cancer in rural India. N Engl J Med. 2009;360(14):1385–94.

    Article  PubMed  CAS  Google Scholar 

  48. Chase DM, Kalouyan M, DiSaia PJ. Colposcopy to evaluate abnormal cervical cytology in 2008. Am J Obstet Gynecol. 2009;200(5):472–80.

    Article  PubMed  Google Scholar 

  49. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, Mahe C, et al. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med. 2005;353(20):2158–68.

    Article  PubMed  CAS  Google Scholar 

  50. Ramogola-Masire D, de Klerk R, Monare B, Ratshaa B, Friedman HM, Zetola NM. Cervical cancer prevention in HIV-infected women using the “see and treat” approach in Botswana. J Acquir Immune Defic Syndr. 2012;59(3):308–13.

    Article  PubMed  Google Scholar 

  51. Van Le L, Broekhuizen FF, Janzer-Steele R, Behar M, Samter T. Acetic acid visualization of the cervix to detect cervical dysplasia. Obstet Gynecol. 1993;81(2):293–5.

    PubMed  Google Scholar 

  52. Visual inspection with Lugol’s iodine (VILI): Evidence to date. 2003. http://www.path.org/publications/files/RH_vili. Accessed 16 Apr 2012.

  53. University of Zimbabwe/JHPIEGO Cervical Cancer Project. Visual inspection with acetic acid for cervical-cancer screening: test qualities in a primary-care setting. Lancet. 1999;353(9156):869–73.

    Google Scholar 

  54. Sangwa-Lugoma G, Mahmud S, Nasr SH, Liaras J, Kayembe PK, Tozin RR, et al. Visual inspection as a cervical cancer screening method in a primary health care setting in Africa. Int J Cancer. 2006;119(6):1389–95.

    Article  PubMed  CAS  Google Scholar 

  55. Sankaranarayanan R, Wesley R, Thara S, Dhakad N, Chandralekha B, Sebastian P, et al. Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol’s iodine (VILI) in cervical cancer screening in Kerala, India. Int J Cancer. 2003;106(3):404–8.

    Article  PubMed  CAS  Google Scholar 

  56. Sehgal A, Singh V, Bhambhani S, Luthra UK. Screening for cervical cancer by direct inspection. Lancet. 1991;338(8762):282.

    Article  PubMed  CAS  Google Scholar 

  57. Blumenthal PD, Gaffikin L, Deganus S, Lewis R, Emerson M, Adadevoh S, et al. Cervical cancer prevention: safety, acceptability, and feasibility of a single-visit approach in Accra, Ghana. Am J Obstet Gynecol. 2007;196(4):407.e1–8. discussion 407.e8-9.

    Article  Google Scholar 

  58. Sankaranarayanan R, Wesley R, Somanathan T, Dhakad N, Shyamalakumary B, Amma NS, et al. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors. Cancer. 1998;83(10):2150–6.

    Article  PubMed  CAS  Google Scholar 

  59. Shi JF, Canfell K, Lew JB, Zhao FH, Legood R, Ning Y, et al. Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study. BMC Cancer. 2011;11:239.

    Article  PubMed  Google Scholar 

  60. Cremer M, Jamshidi RM, Muderspach L, Tsao-Wei D, Felix JC, Blumenthal PD. Digital camera assessment for detection of cervical intraepithelial neoplasia in rural El Salvador. Int J Gynaecol Obstet. 2005;91(1):42–6.

    Article  PubMed  CAS  Google Scholar 

  61. Sankaranarayanan R, Boffetta P. Research on cancer prevention, detection and management in low- and medium-income countries. Ann Oncol. 2010;21(10):1935–43.

    Article  PubMed  CAS  Google Scholar 

  62. McFarland DM. Beliefs about the causes of cervical cancer in Botswana: implications for nursing. Int Nurs Rev. 2009;56(4):426–32.

    Article  PubMed  CAS  Google Scholar 

  63. Dimagi: Mobile Health. http://www.dimagi.com/mobile-health/ (2012). Accessed 16 Apr 2012.

  64. Ferris DG, Macfee MS, Miller JA, Litaker MS, Crawley D, Watson D. The efficacy of telecolposcopy compared with traditional colposcopy. Obstet Gynecol. 2002;99(2):248–54.

    Article  PubMed  Google Scholar 

  65. Williams CM, Kedar I, Smith L, Brandling-Bennett HA, Lugn N, Kvedar JC. Teledermatology education for internal medicine residents. J Am Acad Dermatol. 2005;52(6):1098–9.

    Article  PubMed  Google Scholar 

  66. Shaikh N, Lehmann CU, Kaleida PH, Cohen BA. Efficacy and feasibility of teledermatology for paediatric medical education. J Telemed Telecare. 2008;14(4):204–7.

    Article  PubMed  Google Scholar 

  67. Dennis T, Start RD, Cross SS. The use of digital imaging, video conferencing, and telepathology in histopathology: a national survey. J Clin Pathol. 2005;58(3):254–8.

    Article  PubMed  CAS  Google Scholar 

  68. Ayad E, Yagi Y. Virtual microscopy beyond the pyramids, applications of WSI in Cairo University for E-education & telepathology. Anal Cell Pathol (Amst). 2012;35(2):93–5.

    Google Scholar 

  69. Gongora Jara H, Barcelo HA. Telepathology and continuous education: important tools for pathologists of developing countries. Diagn Pathol. 2008;3 Suppl 1:S24.

    Article  PubMed  Google Scholar 

  70. Latifi K, Lecaj I, Bekteshi F, Dasho E, Doarn CR, Merrell RC, et al. Cost-benefit analysis on the use of telemedicine program of Kosova for continuous medical education: a sustainable and efficient model to rebuild medical systems in developing countries. Telemed J E Health. 2011;17(10):757–62.

    Article  PubMed  Google Scholar 

  71. Condos SG, Stamkopoulos T, Selles JM, Merrell RC. Tele-affiliation in medical education: experience from the international program at Yale Office of Telemedicine. Methods Inf Med. 2002;41(5):382–6.

    PubMed  CAS  Google Scholar 

  72. Mahapatra AK, Mishra SK, Kapoor L, Singh IP. Critical issues in medical education and the implications for telemedicine technology. Telemed J E Health. 2009;15(6):592–6.

    Article  PubMed  Google Scholar 

  73. Ricci MA, Caputo MP, Callas PW, Gagne M. The use of telemedicine for delivering continuing medical education in rural communities. Telemed J E Health. 2005;11(2):124–9.

    Article  PubMed  Google Scholar 

  74. Rafiq A, Merrell RC. Telemedicine for access to quality care on medical practice and continuing medical education in a global arena. J Contin Educ Health Prof. 2005;25(1):34–42.

    Article  PubMed  Google Scholar 

  75. Saiki Jr SM. The role of telemedicine in medical education. Hawaii Med J. 1999;58(12):326–7.

    PubMed  Google Scholar 

  76. Schweickert PA, Rutledge CM, Cattell-Gordon DC, Solenski NJ, Jensen ME, Branson S, et al. Telehealth stroke education for rural elderly Virginians. Telemed J E Health. 2011;17(10):784–8.

    Article  PubMed  Google Scholar 

  77. Kobak KA, Stone WL, Wallace E, Warren Z, Swanson A, Robson K. A web-based tutorial for parents of young children with autism: results from a pilot study. Telemed J E Health. 2011;17(10):804–8.

    Article  PubMed  Google Scholar 

  78. Baker DW, Dewalt DA, Schillinger D, Hawk V, Ruo B, Bibbins-Domingo K, et al. The effect of progressive, reinforcing telephone education and counseling versus brief educational intervention on knowledge, self-care behaviors and heart failure symptoms. J Card Fail. 2011;17(10):789–96.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carrie L. Kovarik .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Wanat, K.A., Quinley, K.E., Kovarik, C.L. (2013). Telemedicine in Cancer Control Programs in Developing Countries. In: Shetty, M. (eds) Breast and Gynecological Cancers. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-1876-4_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-1876-4_15

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-1875-7

  • Online ISBN: 978-1-4614-1876-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics